Security file · CUSIP 02043Q107
ALNY
ALNYLAM PHARMACEUTICALS INC · US listing · held by 1 tracked manager in Q3 2026.
Tracked holders · Q3 2026
1
+0 vs Q2 2026
Aggregate reported value
$495M
sum of holders' reported positions
New holders this quarter
0
1 added · 0 trimmed
Holder return since filing
-2.0%
weighted by each holder's position share · since filing
Ownership · Q3 2026
| Manager | Weight | Shares | Δ shares | Entry | Return | Value | Activity | |
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox Fundsfiled 13 Nov ET | 0.27% | 2.01M | +2.6% | $165 | -2.0% | $495M | Added |
Holder count
Aggregate reported value
Quarterly aggregation
| Quarter | Holders | Δ holders | Aggregate value | Total shares |
|---|---|---|---|---|
| Q3 2026 | 1 | +0 | $495M | 2.01M |
| Q2 2026 | 1 | +0 | $589M | 1.96M |
| Q1 2026 | 1 | +0 | $638M | 1.93M |
| Q4 2025 | 1 | -1 | $781M | 1.96M |
| Q3 2025 | 2 | +1 | $1.06B | 2.32M |
| Q2 2025 | 1 | +0 | $1.04B | 3.20M |
| Q1 2025 | 1 | +0 | $905M | 3.35M |
| Q4 2024 | 1 | +0 | $833M | 3.54M |
| Q3 2024 | 1 | +0 | $996M | 3.62M |
| Q2 2024 | 1 | +0 | $919M | 3.78M |
| Q1 2024 | 1 | +0 | $570M | 3.81M |
| Q4 2023 | 1 | +0 | $703M | 3.67M |
| Q3 2023 | 1 | +0 | $664M | 3.75M |
| Q2 2023 | 1 | — | $720M | 3.79M |